Join

Compare · RVTY vs TXG

RVTY vs TXG

Side-by-side comparison of Revvity Inc. (RVTY) and 10x Genomics Inc. (TXG): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both RVTY and TXG operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
  • RVTY is the larger of the two at $9.68B, about 3.4x TXG ($2.84B).
  • Over the past year, RVTY is down 6.8% and TXG is up 172.9% - TXG leads by 179.7 points.
  • TXG has been more active in the news (7 items in the past 4 weeks vs 6 for RVTY).
  • TXG has more recent analyst coverage (25 ratings vs 18 for RVTY).
PerformanceRVTY-6.77%TXG+172.90%
2025-05-01+0.00%2026-04-30
MetricRVTYTXG
Company
Revvity Inc.
10x Genomics Inc.
Price
$86.67+5.21%
$22.05+9.16%
Market cap
$9.68B
$2.84B
1M return
-1.16%
+3.91%
1Y return
-6.77%
+172.90%
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Laboratory Analytical Instruments
Exchange
NYSE
NASDAQ
IPO
2019
News (4w)
6
7
Recent ratings
18
25
TXG

10x Genomics Inc.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.